Intravesical Bacillus Calmette‐Guérin versus epirubicin for Ta and T1 bladder cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical Bacillus Calmette‐Guérin Versus Epirubicin for Ta and T1 Bladder Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436305/all/images/tooltip-triangle.png. Accessed 30 April 2024.
Intravesical Bacillus Calmette‐Guérin versus epirubicin for Ta and T1 bladder cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436305/all/images/tooltip-triangle.png. Accessed April 30, 2024.
Intravesical Bacillus Calmette‐Guérin versus epirubicin for Ta and T1 bladder cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436305/all/images/tooltip-triangle.png
Intravesical Bacillus Calmette‐Guérin Versus Epirubicin for Ta and T1 Bladder Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436305/all/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical Bacillus Calmette‐Guérin versus epirubicin for Ta and T1 bladder cancer
ID - 436305
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436305/all/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -